Split Chest Breast Neurotization
NCT05757778
Breast Implant; Complications
New York, United States
View Trial DetailsNCT Number: NCT04968457
The aim of the study is to allow Groupe SEBBIN to communicate to competent authorities and to the scientific community data relative to the safety and effectiveness of SEBBIN silicone gel-filled breast implants.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
Female
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At 10 years of follow-up
complication rate
Groupe SEBBIN
Industry
Acronym: IM02
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05757778
Breast Implant; Complications
New York, United States
View Trial DetailsNCT05736354
Breast Implant; Complications, Infection or Inflammation
Carmel, Indiana, United States
View Trial DetailsNCT06274736
Breast Augmentation, Breast Implant; Complications
Coyol, Alajuela Province, Costa Rica
View Trial DetailsNCT03356132
Behavior, Breast Implant; Complications
Niterói, Rio de Janeiro, Brazil
View Trial Details